PATIENT: Jane Smith
AGE: 68 years old
WEIGHT: 72 kg
HEIGHT: 162 cm
GENDER: Female

MEDICAL RECORD NUMBER: 12345678
DATE: January 15, 2024

CHIEF COMPLAINT:
Scheduled for elective laparoscopic cholecystectomy

HISTORY OF PRESENT ILLNESS:
68-year-old female with symptomatic cholelithiasis. Recurrent episodes of biliary colic over the past 6 months. No acute cholecystitis. Candidate for laparoscopic approach.

PAST MEDICAL HISTORY:
- Hypertension (well-controlled)
- Type 2 Diabetes Mellitus 
- Coronary Artery Disease, status post PCI 2019
- Chronic kidney disease stage 3
- Sleep apnea on CPAP
- GERD

MEDICATIONS:
- Metoprolol 50mg BID
- Lisinopril 10mg daily  
- Insulin glargine 24 units nightly
- Metformin 1000mg BID
- Aspirin 81mg daily
- Atorvastatin 40mg daily
- Omeprazole 20mg daily

ALLERGIES: 
Penicillin (rash), Morphine (nausea)

SOCIAL HISTORY:
Non-smoker. Occasional alcohol use. Lives with spouse.

PHYSICAL EXAMINATION:
Vital Signs: BP 142/78, HR 68, RR 18, O2 Sat 96% on RA
General: Alert, cooperative, no acute distress
Airway: Mallampati Class II, good mouth opening 4cm, full neck mobility
Cardiovascular: Regular rate and rhythm, no murmurs
Pulmonary: Clear to auscultation bilaterally
Abdomen: Soft, mild RUQ tenderness

LABORATORY VALUES:
CBC: Hemoglobin 11.8 g/dL, Platelets 245 K/uL, WBC 6.2
BMP: Creatinine 1.4 mg/dL, Glucose 156 mg/dL, Na 138, K 4.1
Coagulation: INR 1.0, PT 11.2, PTT 28

ASA PHYSICAL STATUS: ASA III

PLANNED PROCEDURE:
Laparoscopic cholecystectomy
Surgeon: Dr. Johnson
Estimated duration: 1.5-2 hours
Position: Supine with reverse Trendelenburg
Expected blood loss: minimal

NPO STATUS: NPO since midnight (12 hours)

ANESTHESIA PLAN:
General anesthesia with endotracheal intubation
Standard ASA monitors
Peripheral IV access
Post-operative: PACU recovery, home same day if stable

SPECIAL CONSIDERATIONS:
- Continue metoprolol morning of surgery
- Hold Lisinopril morning of surgery  
- Last insulin dose given as scheduled
- OSA - plan for careful emergence and monitoring
- CKD - avoid nephrotoxic agents, consider fluid management 